Larvol Delta - Ankyra-Therapeutics-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-with-Merck-to-Evaluate-ANK101-in-Combination-with-KEYTRUDA-pembrolizumab-in-Patients-with-Advanced-Solid-Tumors

ANK-101 - Ankyra Therap

Keytruda (pembrolizumab) - Merck (MSD)

https://www.businesswire.com/news/home/20231004287654/en/Ankyra-Therapeutics-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-with-Merck-to-Evaluate-ANK-101-in-Combination-with-KEYTRUDA%C2%AE-pembrolizumab-in-Patients-with-Advanced-Solid-Tumors

Oct 4, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next